
|Videos|February 26, 2016
Dr. Sheri Holmen on Finding the Appropriate Treatments for Brain Metastases in Melanoma
Author(s)Sheri Holmen, PhD
Holmen says that utilizing targeted therapies could potentially be the answer, though clinically-tested combinations have historically not done as well as clinicians had hoped.
Advertisement
Sheri Holmen, PhD, associate professor, Department of Surgery, University of Utah School of Medicine, discusses options for treating brain metastases in melanoma. Holmen says that utilizing targeted therapies could potentially be the answer, though clinically-tested combinations have historically not done as well as clinicians had hoped. She adds that combinations are still on the table in terms of treating brain metastases in melanoma, both with other targeted therapies, as well as immunotherapies.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
4
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
5








































